Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
-
- STATUS
- Not Recruiting
-
- participants needed
- 28
-
- sponsor
- GlaxoSmithKline
Updated on 22 July 2024
Summary
This study in PD patients is designed to assess the affect food has on the absorption, distribution, metabolism and excretion of ropinirole (by dosing some patients in the fasted state and other patients following a high-fat breakfast), and to assess the difference in absorption, distribution, metabolism and excretion of ropinirole if patients are given three 4mg ropinirole tablets versus one 12mg tablet.
Details
| Condition | Parkinson Disease |
|---|---|
| Age | 30years - 85years |
| Treatment | Ropinirole |
| Clinical Study Identifier | NCT00460148 |
| Sponsor | GlaxoSmithKline |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.